Cyxone AB Logo

Cyxone AB

CYXO | ST

Overview

Corporate Details

ISIN(s):
SE0007815428 (+2 more)
LEI:
54930034OH16ROAY4K87
Country:
Sweden
Address:
Hyllie Boulevard 34, 215 32 Malmö
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Cyxone AB develops disease-modifying therapies for autoimmune diseases.

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
No filings match the current criteria.

Insider Transactions

Date Insider Name Position Type Shares Value
2023-06-28 Carl Magnus Högerkorp Other Buy 64,950 40,788.60 SEK
2023-06-27 Carl Magnus Högerkorp Other Buy 6,050 3,690.50 SEK
2023-03-03 Carl Magnus Högerkorp Other Buy 100,010 51,005.10 SEK
2023-03-02 Carl Magnus Högerkorp Other Buy 10,873 5,653.96 SEK
2021-07-15 Bert Junno Other Other 1,788,732 7,763,096.88 SEK
2021-07-15 Bert Junno Other Other 1,788,732 N/A
2021-07-14 Bert Junno Other Other 1,788,786 7,790,163.03 SEK
2021-07-14 Bert Junno Other Other 1,788,786 N/A
2021-07-12 Mikeoo Holding AB Other Other 1,788,732 7,441,125.12 SEK
2021-07-12 Mikael Lindstam Other Other 1,788,732 N/A

Peer Companies

Company Country Ticker View
Curevac Logo Curevac Germany CVAC
Cyclezyme AB Logo Cyclezyme AB Sweden CYCLE
DBV Technologies Logo DBV Technologies France DBV
DEINOVE Logo DEINOVE France ALDEI
Deutsche Biotech Innovativ AG Logo Deutsche Biotech Innovativ AG Germany DBI
Devyser Diagnostics Logo Devyser Diagnostics Sweden DVYSR
Diamyd Medical AB (publ) Logo Diamyd Medical AB (publ) Sweden DMYD
Diasorin Logo Diasorin Italy DIA
DNA Group (T.R.) Ltd. Israel DNA
Double Bond Pharmaceutical International AB Logo Double Bond Pharmaceutical International AB Sweden DBP B